Cambridge Epigenetix

Verified

Cambridge Epigenetix is using epigenetics to reduce diagnostic tests for common cancers to a simple blood draw. Biotech Healthcare Medical

Company News Cambridge Epigenetix Team Profile Startup Startups Series D Route United Kingdom News

About Cambridge Epigenetix

Cambridge Epigenetix is tracked on 100Xfounder as a startup company, founded in 2012, based in London, England, United Kingdom, currently mapped to the Series D stage. Cambridge Epigenetix is using epigenetics to reduce diagnostic tests for common cancers to a simple blood draw. Biotech Healthcare Medical

Profile snapshot: Founders linked: Cambridge Epigenetix Team. Funding tracked: $88.00M. Hiring focus: Open Roles. Tech tags: AWS, React, Python, and PostgreSQL.

Recent signals:

Cambridge Epigenetix appears in the 100Xfounder startup directory import feed.

Why it Matters

Cambridge Epigenetix is worth tracking because its funding history is already mapped here, including a $88.00M round, the hiring signal points to active work across Open Roles roles, recent coverage is already tied back to this page, and Cambridge Epigenetix Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $88.00MLast Round: Series D Sequoia, $88M Series D in 2021, $350M valuationAll Rounds: 1

Series D | Sequoia, $88M Series D in 2021, $350M valuation

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Cambridge Epigenetix Team

Founder & CEO

Founder Profile LinkedIn

Tech Stack

AWSReactPythonPostgreSQL

Last updated: May 12, 2026

Cambridge Epigenetix research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

Company summary
Cambridge Epigenetix is using epigenetics to reduce diagnostic tests for common cancers to a simple blood draw. Biotech Healthcare Medical
Founders covered
Cambridge Epigenetix Team
Market position
Startup | Series D | London, England, United Kingdom
Newsroom signal
No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.
Funding signal
$88.00M

Best next clicks

Company News Hub Cambridge Epigenetix Team United Kingdom News Startup Startups Series D Funding News

Active topics

Startup News Founder Intelligence

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Startup with comparable market signals.

Varda

Varda Team

View Company Industry Hub

Flexport

Flexport Team

View Company Industry Hub

DevRev

DevRev Team

View Company Industry Hub

insitro

insitro Team

View Company Industry Hub

PatSnap

PatSnap Team

View Company Industry Hub

Solugen

Solugen Team

View Company Industry Hub

Gong.io

Gong.io Team

View Company Industry Hub

Klook

Klook Team

View Company Industry Hub

Discover Now

Newsroom and topic pages connected to Cambridge Epigenetix.

Company News Hub Topic Hubs Funding News

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Company profile→Founder profile→United Kingdom startup directory→Startup hub→Startup startup list→Series D startup list→Series D newsroom→Startup startups in United Kingdom→Founder directory→Startup directory→

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

Contact Editorial Get Featured

FAQs About Cambridge Epigenetix

Common questions people ask about this profile.

What is Cambridge Epigenetix?

Cambridge Epigenetix is using epigenetics to reduce diagnostic tests for common cancers to a simple blood draw. Biotech Healthcare Medical

Who founded Cambridge Epigenetix?

Cambridge Epigenetix is associated with Cambridge Epigenetix Team on 100Xfounder.

Where is Cambridge Epigenetix located?

Cambridge Epigenetix is listed in London, England, United Kingdom.

What stage is Cambridge Epigenetix in?

Cambridge Epigenetix is currently mapped to Series D. Funding context: Sequoia, $88M Series D in 2021, $350M valuation

What is the latest funding round of Cambridge Epigenetix?

Cambridge Epigenetix's latest tracked round is Series D Sequoia, $88M Series D in 2021, $350M valuation. Total tracked rounds: 1.

Is Cambridge Epigenetix hiring now?

Cambridge Epigenetix hiring status: Open Roles.

What technologies does Cambridge Epigenetix use?

Cambridge Epigenetix is associated with AWS, React, Python, and PostgreSQL.

Is Cambridge Epigenetix verified on 100Xfounder?

Yes. Cambridge Epigenetix is currently marked verified on 100Xfounder as of May 12, 2026.

How can users connect with Cambridge Epigenetix founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.